COMPASS Pathways Plc - American Depository Shares (CMPS)
$7.86
0.10 (1.26%)
CMPS Stock Quote Delayed 30 Minutes
The 3 Best Psychedelic Stocks to Buy Now
Psychedelic stocks promise to bring therapeutics to market that were taboo until recently and have huge upside.
11 Best Stocks to Buy for 2023
INSIDE: Investing legend Louis Navellier reveals his Top 11 Stocks for 2023 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
266,921
Day's Range
$7.79 - $8.07
52-Week Range
$6.97 - $12.88
Dividend & Yield
N/A (N/A)
CMPS Stock Predictions, Articles, and COMPASS Pathways Plc - American Depository Shares News
Compass Pathways (CMPS): The McDonald’s of Psychedelics?
This week, we’re talking about my Big Three investing themes for the rest of the year (and beyond), which includes a psychedelic stock favorite, Compass Pathways (CMPS).
Dear Psychedelic Stocks Fans, Watch This Key Catalyst
Psychedelic stocks are in focus following new legislation from both the Senate and the House that has bipartisan support.
Growing Psychedelic Interest Will Help Push Compass Pathways Stock Up 3X By 2022
By 2030, psychedelic therapy will be the gold standard for mental health treatment. And Compass is at the forefront of commercialization.
Compass Pathways Offers Chance on Exploratory Mental Health Treatments
Over the past year, CMPS stock has been going nowhere fast. However, there's been recent progress in advancing psilocybin-assisted therapy.
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
So what did the stock market do today? All eyes were on Bitcoin prices, EV stocks and hype in the psychedelics market.
MNMD Stock: A MindMed Buzz Kill as the Psychedelic Shares Tank on First Day of Trading
MindMed (MNMD) stock isn't doing so hot with shares taking a beating on the first day of trading at their new home on the Nasdaq.
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
So what did the stock market do today? All eyes were on Tesla stock as it set a new record and MNMD stock ahead of its listing.
The Shroom Boom Is Here. Buy CMPS Stock to Ride This Explosive Megatrend.
IPOs. Uplistings. Academic studies. All the stars are aligning for "shroom stocks", so it's time to buy CMPS stock on the dip.
Find Your Next 10X Winner in the Burgeoning Shroom Boom
Psychedelic stocks are going to surge as the once "hardcore" group of pschedelic drugs gains widespread mainstream medicinal acceptance.
4 Megatrends the Election Has Kicked Into Hyperdrive
These four megatrends are in high gear after the 2020 Presidential election. These are the best stocks to buy now.
